// App-Quantinova.ai

3889 : Novel drug candidates cep1430 and cep1507 for targeting pancreatic patient-derived xenograft cancer stem cell and circulating tumor cell models

Researchers

Presenter

  • Michael Sharma

Principal Investigators

  • Maulik Jain

  • Cristian Sharma

  • Karina Amezcua

  • Natalee Amezcua

  • Reed Hasson

  • Miriam Navel

  • Donna Stanton

  • Satya Narayan

  • Karl Kramberger

  • Rubio Punzalan

  • Jitesh Jani

  • Douglas Foster

  • Jay P. Sharma

Medical Centers

  • Celprogen, Inc., Torrance, CA

  • Ross Medical School, Dominica, Dominica

  • University of Florida, Florida, FL.

Locations

  • United States

  • Dominica

Companies

  • Celprogen Inc.

Study Components

Therapeutic Area

  • Oncology (ONC)

  • Gastroenterology (GU)

Disease

  • N/A

Biomarkers

  • Circulating tumor cells

Drug/Treatment

  • Gemcitabine

Outcome

  • N/A

Study Design

  • N/A

Phase

  • NA

Study Id's

  • N/A

Sponsors

  • N/A

Result

  • N/A

Copyright © 2026. QuantiNova All rights reserved